ReviewTherapeutic advances in neurological disorders2016

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.

Nicolas Collongues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.